* Login   * Register * FAQ    * Search
It is currently Tue Sep 02, 2014 12:44 am

All times are UTC - 6 hours


Post new topic Reply to topic  [ 1 post ] 
Author Message
PostPosted: Fri Mar 06, 2009 1:29 pm 
Offline
Over 100 Posts!
User avatar

Joined: Mon Jun 23, 2003 6:36 am
Posts: 478
Location: New York, NY
Public release date: 5-Mar-2009
[ Print Article | E-mail Article | Close Window ]

Contact: Amy Gleason Quarshie
agleason@liebertpub.com
914-740-2149
Mary Ann Liebert, Inc./Genetic Engineering News

Support for adjunctive vitamin C treatment in cancer
New Rochelle, NY, March 5, 2009—Serious flaws in a recent study, which concluded that high doses of vitamin C reduce the effectiveness of chemotherapeutic drugs in the treatment of cancer, are revealed in the current issue of Alternative and Complementary Therapies, a journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). This report is available free online at www.liebertpub.com/act

In the Medical Journal Watch column of the latest issue, Jack Challem, a personal nutrition coach and nutrition author from Tucson, Arizona, and a regular contributor to the Journal, challenges the findings of a study published in Cancer Research (2008;68:8031-8038), in which the authors conclude that vitamin C given to mice or cultured cells treated with common anti-cancer drugs reduces the antitumor effects of the chemotherapeutic agents.

Challem points out two main problems with the study: the oxidized form of vitamin C (dehydroascorbic acid) and not actual vitamin C (ascorbic acid) was used; and in the mouse experiments, the animals were given toxic doses of dehydroascorbic acid, a compound that is not used as a dietary supplement in humans.

"This study and the subsequent headlines [it generated] were a grievous disservice to physicians and patients with cancer," says Challem. He adds that "considerable positive research…has shown striking benefits from high-dose vitamin C (ascorbic acid) in cancer cells and animals—and in actual human beings."

High-dose intravenous vitamin C is a common form of alternative and complementary therapy for patients receiving chemotherapeutic drugs and is believed to help bring about tumor cell death. In addition, it may promote postsurgical healing by enhancing collagen formation, and increase tissue resistance to tumor spread.

Challem suggests that, "The ideal therapeutic approach would be to tailor individual treatment, including IV vitamin C, from a menu of options."


###

_________________
Alisa
single mother of twin boys
diagnosed at 43 yrs. old
NSCLC dx. July 2000, Stage IIIa
lobectomy; 6 cycles taxol/carboplatin
followup w/traditional chinese medicine
(consisting of chinese herbs and many supplements/vitamins)
Celebrex 200 mg 2x/day
OPC and ORAC (2 top super antioxidants)
No Evidence of Disease since January, 2001
Lost Mother/Grandfather/Aunts and Uncles all to nsclc
Lost Father to prostate ca.that spread to lungs


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC - 6 hours


Who is online

Users browsing this forum: No registered users and 1 guest


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot post attachments in this forum

Search for:
Jump to:  
Powered by phpBB® Forum Software © phpBB Group
[ Time : 1.045s | 13 Queries | GZIP : Off ]